NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer

Cell Death & Disease, Published online: 18 July 2020; doi:10.1038/s41419-020-02753-xNCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer

Source: Cell death and disease - July 17, 2020 Category: Internal Medicine Authors: Lili Jiang Liangliang Ren Han Chen Jinyuan Pan Zhuojun Zhang Xiangqin Kuang Xuhong Chen Wenhao Bao Chun Lin Zhongqiu Zhou Danping Huang Jianan Yang Hongbiao Huang Lan Wang Ning Hou Libing Song Source Type: research